Inovio Receives European Medicines Agency Certification For Qu...
PLYMOUTH MEETING, PA., May 7, 2019 /PRNewswire-AsiaNet/-- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certification of q...
Authors: LATEST ASIANET NEWS RELEASES